definiens: within the meaning of Section 27A of theSecurities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 . Because such statements deal withfuture events and are based on Atara Bio ’s current expectations, they are subject to various risks and uncertaintiesand actual results, performance or achievements of Atara Bio could differ materially from those described in or impliedby the statements in this press release . For example, forward - looking statements include statements regarding theclinical development of product candidates and Atara Bio ’s collaboration with MSK . These forward - looking statementsare subject to other risks and uncertainties, including those discussed under the heading in Atara Bio’squarterly report on Form 10 - Q for the quarter ended March 31, 2015 and subsequent filings with the Securities andExchange Commission . Except as otherwise required by law, Atara Bio disclaims any intention or obligation to updateor revise any forward - looking statements, which speak only as of the date hereof, whether as a result of newinformation, future events or circumstances or otherwise